title: When and why to use FDG PET/CT in locally advanced rectal cancer: two scenarios.
authors.affiliation: From the Departments of *Nuclear Medicine, PET Unit, †Surgery, and ‡Radiotherapy, Santa Maria della Misericordia Hospital, Rovigo, Italy; and §Department of Radiology, University of Southern California, Los Angeles, CA.
authors.forename: Anna Margherita
authors.initials: AM
authors.lastname: Maffione
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Galeotti
authors.forename: Carlo
authors.initials: C
authors.lastname: Capirci
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Colletti
authors.forename: Domenico
authors.initials: D
authors.lastname: Rubello
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D064847:Multimodal Imaging; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D012004:Rectal Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D014057:Tomography, X-Ray Computed
chemical_list: D019788:Fluorodeoxyglucose F18